©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 110203
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110203
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110203
Table 4 Location of the metastasis, n (%)
| Variables | n = 52 |
| Organ | |
| Liver | 22 (42.3) |
| Bone | 9 (17.3) |
| Non-regional lymph node | 4 (7.7) |
| Pancreas | 3 (5.8) |
| Lung | 3 (5.8) |
| Prostate | 2 (3.8) |
| Soft tissue | 1 (1.9) |
| Ovary | 1 (1.9) |
| Cervix | 1 (1.9) |
| Bladder | 1 (1.9) |
| Vagina | 1 (1.9) |
| Adrenal | 1 (1.9) |
| Number of metastatic organs | |
| 0 | 29 (55.8) |
| 1 | 10 (19.2) |
| 2 | 6 (11.5) |
| 3 | 3 (5.8) |
| 4 | 2 (3.8) |
| 5 | 2 (3.8) |
| Liver lesions, n = 22 | |
| Single | 1 (4.5) |
| Multiples | 21 (95.5) |
| Bulky liver tumor, as volume involvement > 25%, n = 22 | |
| Yes | 13 (59.1) |
| No | 9 (40.9) |
- Citation: Cruz-Diaz WE, Leonardo A, Saavedra A, Paitan V, Haro-Varas J, Mantilla R, Macetas J, Veramendi E, Pacheco C, Calderón M, Vidaurre T, Castro-Oliden V. Rectal neuroendocrine tumors in a Latin American population: Insights from a Peruvian national cancer institute. World J Gastrointest Oncol 2025; 17(10): 110203
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/110203.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.110203